Smoking Cessation Support for Patients With Rheumatologic Diseases Via WhatsApp
- Conditions
- Tobacco Use Cessation
- Interventions
- Other: Mobile messages via What's App
- Registration Number
- NCT06219551
- Lead Sponsor
- Recep Tayyip Erdogan University Training and Research Hospital
- Brief Summary
Smoking cessation support for patients with rheumatologist diseases is an underestimated issue. In the previous prospective cohort study the investigators determined that with the brief cessation interventions 63.5% of smokers with rheumatologic diseases were willing to quit and the rest 36.4% were not willing. Among the willing group the highest quit rate was detected in the group that admitted to smoking cessation clinic. Therefore to increase the willingness to quit as well as to increase the Access to evidence based tobacco cessation support using new comminication technologies can be relevant. Investigators' aim in this study is to examine the effect of including WhatsApp in the routine smoking cessation practices on the quitting success of active smokers with rheumatic diseases who apply to the Rheumatology outpatient clinic.
- Detailed Description
In this randomized controlled study, the sample will be randomly divided to 2 arms. In one arm, usual care arm, smoker patients with rheumatologist diseases will be implemented brief smoking cessation interventions and referred to quit lines or smoking cessation services and also directly contacted to get an appointment from the cessation clinic. In the other arm, the intervention arm, smoker patients with rheumatologist diseases will be implemented brief tobacco cessation interventions and directly contacted to get an appointment from cessation clinic and will be send periodically motivational and informative text messages regarding tobacco cessation via WhatsApp.
Primary outcome measures will be the quit rate of both arms at 3rd, 6th and 12th month.
Secondary outcomes will be access to evidence based smoking cessation support, admission rate of smoking cessation clinic and treatment use duration of cessation medications.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 220
- Patients applying to the rheumatology outpatient clinic
- Those aged 18 and over
- Those who are active smokers
- Those diagnosed with inflammatory rheumatic disease
- Those who gave informed written consent to participate in the study
- Those with active psychiatric disease diagnoses such as psychosis, major depression, schizophrenia among their current diagnoses
- Those with cognitive dysfunction
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual care Mobile messages via What's App Usual care arm, smoker patients with rheumatologist diseases will be implemented brief smoking cessation interventions and referred to quit lines or smoking cessation services and also directly contacted to get an appointment from the cessation clinic. Intervention Mobile messages via What's App The intervention arm, smoker patients with rheumatologist diseases will be implemented brief tobacco cessation interventions and directly contacted to get an appointment from cessation clinic and will be send periodically motivational and informative text messages regarding tobacco cessation via WhatsApp.
- Primary Outcome Measures
Name Time Method Rate of participants with successful quit attempt 3-6 and 12 months after the randomization Successful quitter: sustained abstinence since the target quit date will be asked and validated by exhaled breath carbon monoxide measure.
- Secondary Outcome Measures
Name Time Method Access to evidence based cessation support Within one year after the randomization Admitters to cessation clinics
Trial Locations
- Locations (1)
Recep Tayyip Erdoğan University, Training and Research Hospital
🇹🇷Rize, Turkey